• Log in
  • Educational Programs
  • Faculty Profiles
  • Podcasts
  • Valued Partners
  • Library
  • Contact Us

Please Log in

Already a member? Log in

* required

Log in
Educational Programs
Faculty Profiles
Podcasts
Valued Partners
Library
Contact Us

Membership

Please become a Melody.education Member to view available programs, and receive updates on future releases.

*=required

Educational Programs

Introduction with Keith Miller, PhD

Definitions and Epidemiology; Pathophysiology; Natural History of the Disease; Morbidity and Mortality with Christina Hanson, MS, FNP

Identifying Risk Factors; Patient Identification; Patient Perspective with Ann Moore, FNP-C

Treating Patients With NASH and Significant Fibrosis – Are we doing Enough? with Prof Quentin M. Anstee, MD

Treating Patients With NASH and Significant Fibrosis – Now and in the Future with Prof Jörn M. Schattenberg, MD

Treating Patients With NASH and Significant Fibrosis – What does the Future Hold? with Prof Stephen A. Harrison, MD, FACP, FAASLD

Definitions, Epidemiology & Comorbidities; Pathophysiology with Mazen Noureddin, MD, MHSc

Morbidity & Mortality; Patient Identification; Patient Perspective with Marcelo Kugelmas, MD, FAASLD, FACP

Part I - Fatty Liver Foundation Development with Wayne Eskridge with Wayne Eskridge

Part II - Advice for Patients with Recent Diagnosis of NASH with Fibrosis with Wayne Eskridge

Part III - After Diagnosis: What Happens Now? with Wayne Eskridge and Scott L. Friedman, MD